VDR Haploinsufficiency Impacts Body Composition and Skeletal Acquisition in a Gender-Specific Manner
- 162 Downloads
The vitamin D receptor (VDR) is crucial for virtually all of vitamin D’s actions and is thought to be ubiquitously expressed. We hypothesized that disruption of one allele of the VDR gene would impact bone development and would have metabolic consequences. Body composition and bone mass (BMD) in VDR heterozygous (VDR HET) mice were compared to those obtained in male and female VDR KO and WT mice at 8 weeks of age. Male mice were also evaluated at 16 weeks, and bone marrow mesenchymal stem cell (MSC) differentiation was evaluated in VDR female mice. Additionally, female VDR HET and WT mice received intermittent PTH treatment or vehicle (VH) for 4 weeks. BMD was determined at baseline and after treatment. MRI was done in vivo at the end of treatment; μCT and bone histomorphometry were performed after killing the animals. VDR HET male mice had normal skeletal development until 16 weeks of age but showed significantly less gain in fat mass than WT mice. In contrast, female VDR HET mice showed decreased total-body BMD at age 8 weeks but had a normal skeletal response to PTH. MSC differentiation was also impaired in VDR HET female mice. Thus, female VDR HET mice show early impairment in bone acquisition, while male VDR HET mice exhibit a lean phenotype. Our results indicate that the VDR HET mouse is a useful model for studying the metabolic and skeletal impact of decreased vitamin D sensitivity.
KeywordsVitamin D Parathyroid hormone Body composition
We thank Terry M. Handerson and Marilena Preda for technical assistance in μCT and MRI exams, respectively. F. J. A. P. received financial support from the National Council for Scientific and Technological Development (CNPq), Brazil (201650/2008-8). I. D.-P. received financial support from CAPES, Brazil (0102-09-1).
- 6.Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB (1999) Rescue of the skeletal phenotype of vitamin D receptor–ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140:4982–4987PubMedCrossRefGoogle Scholar
- 12.Lecka-Czernick B, Ackert-Bicknell C, Adamo L, Marmolejos V, Churchill GA, Shockley KR, Reid IR, Grey A, Rosen CJ (2007) Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo. Endocrinology 148:903–911CrossRefGoogle Scholar
- 16.Dardenenne O, Prud’homme J, Hacking SA, Glorieux FH, St. Arnaud R (2003) Rescue of the pseudo-vitamin D deficiency rickets phenotype of CYP27B1-deficient mice by treatment with 1,25-dihydroxyvitamin D3: biochemical, histomorphometric, and biomechanical analyses. J Bone Miner Res 18:637–643CrossRefGoogle Scholar
- 25.Panda DK, Miao D, Bolivar I, Li J, Huo R, Hendy GN, Goltzman D (2004) Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 279:16754–16766PubMedCrossRefGoogle Scholar
- 34.Shi H, Norman AW, Okamura WH, Sen A, Zemel MB (2002) 1α,25-Dihydroxyvitamin D3 inhibits uncoupling protein 2 expression in human adipocytes. J FASEB 16:1808–1810Google Scholar